🔎 Trials Near Me

Home › Urogenital Cancer › Missouri

Pag-aaral pangklinika para sa Urogenital Cancer sa Missouri

5 pag-aaral para sa Urogenital Cancer ang naghahanap ng mga kalahok sa mga site sa Missouri.

Mga Lungsod sa Missouri

Opisyal na teksto ng pag-aaral (English)

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

  • Cox Cancer Center Branson, Branson
  • Mercy Hospital Joplin, Joplin
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • at 6 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215624

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • at 11 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  • Missouri Cancer Associates, Columbia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07566156

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Missouri, Columbia
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT04354064

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.